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Diabetes mellitus is a complex metabolic Diabetes mellitus is a complex metabolic disorder characterised by persistent hyperdisorder characterised by persistent hyperglycaemia resulting from defects in insulin glycaemia resulting from defects in insulin secretion, insulin action or both. The two secretion, insulin action or both. The two main types of diabetes mellitus are type 1 main types of diabetes mellitus are type 1 (formerly known as insulin-dependent (formerly known as insulin-dependent diabetes), and type 2 (formerly known as diabetes), and type 2 (formerly known as non-insulin-dependent diabetes). Type 1 non-insulin-dependent diabetes). Type 1 diabetes is caused by the autoimmune diabetes is caused by the autoimmune destruction of the destruction of the b b-cells of the pancreatic -cells of the pancreatic islets, whereas type 2 diabetes results from islets, whereas type 2 diabetes results from both impaired insulin secretion and resisboth impaired insulin secretion and resistance to the action of insulin. Diabetes tance to the action of insulin. Diabetes affects around 3% of the adult UK affects around 3% of the adult UK population (Bennett population (Bennett et al et al, 1995) . As the , 1995). As the prevalence increases with age, the lifetime prevalence increases with age, the lifetime risk of developing diabetes is around 10% risk of developing diabetes is around 10% (Neil (Neil et al et al, 1987 (Neil et al et al, ). , 1987 . Diabetes is associated with premature Diabetes is associated with premature mortality, predominantly through atheromortality, predominantly through atherosclerotic vascular disease (World Health sclerotic vascular disease (World Health Organization/International Diabetes FedOrganization/International Diabetes Federation, 1999) . Microvascular complicaeration, 1999) . Microvascular complications, which affect the small blood vessels tions, which affect the small blood vessels in the eye, kidney and nerves, are associated in the eye, kidney and nerves, are associated with considerable morbidity. The economic with considerable morbidity. The economic and social costs of diabetes are enormous, and social costs of diabetes are enormous, both for health care services and through both for health care services and through loss of productivity. In developed countries, loss of productivity. In developed countries, 10% or more of the total health budget is 10% or more of the total health budget is spent on the management of diabetes and spent on the management of diabetes and its complications (Jonsson, 2002; Zimmet its complications (Jonsson, 2002; Zimmet et al et al, 2003) .
, 2003). The prevalence of type 2 diabetes is The prevalence of type 2 diabetes is increased in patients with schizophrenia increased in patients with schizophrenia compared with the general population compared with the general population (Holt (Holt et al et al, 2004) . Although many factors, , 2004) . Although many factors, including genetic and lifestyle issues, contriincluding genetic and lifestyle issues, contribute to this association, there has been a bute to this association, there has been a recent surge in interest in the subject recent surge in interest in the subject because of the possible link between the because of the possible link between the use of atypical antipsychotic drugs and the use of atypical antipsychotic drugs and the development of diabetes. The increased development of diabetes. The increased prevalence of type 2 diabetes among people prevalence of type 2 diabetes among people with schizophrenia has implications for with schizophrenia has implications for the delivery of care by psychiatrists, as the delivery of care by psychiatrists, as well as for diabetologists and general well as for diabetologists and general practitioners. The purpose of this paper is practitioners. The purpose of this paper is therefore to provide an update on current therefore to provide an update on current thinking about diabetes for practising psythinking about diabetes for practising psychiatrists, in order to improve the physical chiatrists, in order to improve the physical health of their patients. Since type 2 diahealth of their patients. Since type 2 diabetes is the primary cause of concern for betes is the primary cause of concern for patients with schizophrenia, it is the main patients with schizophrenia, it is the main focus of this review. focus of this review.
METHOD METHOD
The current diabetes literature, the NaThe current diabetes literature, the National Service Framework for Diabetes, tional Service Framework for Diabetes, the National Institute for Clinical Excelthe National Institute for Clinical Excellence guidance on the management of dialence guidance on the management of diabetes and literature produced by Diabetes betes and literature produced by Diabetes UK were reviewed. UK were reviewed.
RESULTS RESULTS

A brief history of diabetes A brief history of diabetes
The oldest description of diabetes as a The oldest description of diabetes as a polyuric state dates back to 1550 polyuric state dates back to 1550 BC BC in anin ancient Egypt. The word 'diabetes', derived cient Egypt. The word 'diabetes', derived from the Greek meaning 'siphon' or 'pass from the Greek meaning 'siphon' or 'pass through', was first used by Aretaeus of through', was first used by Aretaeus of Cappadocia in the 2nd century Cappadocia in the 2nd century AD AD when when he gave a clinical description of the disease. he gave a clinical description of the disease. In the 5th and 6th centuries, Indian physiIn the 5th and 6th centuries, Indian physicians recognised the sweet, honey-like taste cians recognised the sweet, honey-like taste of urine from polyuric patients, which of urine from polyuric patients, which attracted ants and insects. The Indian deattracted ants and insects. The Indian descriptions of diabetes mellitus also recogscriptions of diabetes mellitus also recognised the distinction between two forms of nised the distinction between two forms of diabetes: one in older, fatter people, and diabetes: one in older, fatter people, and the other in thin people who rapidly the other in thin people who rapidly succumbed to their illness. succumbed to their illness.
The sweetness in the urine was redisThe sweetness in the urine was rediscovered by the Englishman Thomas Willis, covered by the Englishman Thomas Willis, physician to King Charles II in the 17th physician to King Charles II in the 17th century, who also noted the importance century, who also noted the importance of lifestyle when he remarked that the preof lifestyle when he remarked that the prevalence of diabetes was increasing because valence of diabetes was increasing because of 'good fellowship and gusling down of 'good fellowship and gusling down chiefly of unalloyed wine'. A century later, chiefly of unalloyed wine'. A century later, Matthew Dobson in 1776 showed that the Matthew Dobson in 1776 showed that the urinary sweetness was caused by sugar and urinary sweetness was caused by sugar and was associated with a rise in blood sugar. was associated with a rise in blood sugar. At the turn of the 18th century, John At the turn of the 18th century, John Rollo was the first person to use the term Rollo was the first person to use the term 'diabetes mellitus' (honey) to distinguish 'diabetes mellitus' (honey) to distinguish the condition from 'diabetes insipidus' the condition from 'diabetes insipidus' (tasteless). (tasteless).
Claude Bernard, a French physiologist, Claude Bernard, a French physiologist, made several important advances in the made several important advances in the 19th century when he discovered that 19th century when he discovered that sugar was stored in the liver in the form sugar was stored in the liver in the form of glycogen, and that transfixion of the of glycogen, and that transfixion of the medulla in conscious rabbits caused hypermedulla in conscious rabbits caused hyperglycaemia. Paul Langerhans, also working glycaemia. Paul Langerhans, also working s 5 5 s 5 5 Although insulin has major actions on Although insulin has major actions on lipid and protein metabolism, this historical lipid and protein metabolism, this historical perspective explains why the focus of perspective explains why the focus of diabetic management has been the normaldiabetic management has been the normalisation of blood glucose levels and why the isation of blood glucose levels and why the diagnosis of diabetes is based on the finding diagnosis of diabetes is based on the finding of chronic hyperglycaemia. of chronic hyperglycaemia.
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Diagnosis of diabetes Diagnosis of diabetes
Before the late 1970s, there was no consenBefore the late 1970s, there was no consensus on the diagnostic criteria for diabetes. sus on the diagnostic criteria for diabetes. This led to much confusion and precluded This led to much confusion and precluded any meaningful comparison of the prevaany meaningful comparison of the prevalence of diabetes within or between populalence of diabetes within or between populations (West, 1975) . In 1965 the World tions (West, 1975) . In 1965 the World Health Organization (WHO) prepared its Health Organization (WHO) prepared its first expert report on the diagnosis of diafirst expert report on the diagnosis of diabetes, and these diagnostic criteria were betes, and these diagnostic criteria were subsequently modified and simplified by subsequently modified and simplified by the WHO and the National Diabetes Group the WHO and the National Diabetes Group in the USA in 1979 , 1980 and 1985 . The in the USA in 1979 , 1980 and 1985 Although the diagnostic criteria of the Although the diagnostic criteria of the WHO have a slightly different emphasis WHO have a slightly different emphasis to those of the ADA, for clinical and to those of the ADA, for clinical and epidemiological purposes they are essenepidemiological purposes they are essentially identical, and can be considered to tially identical, and can be considered to represent an international consensus. represent an international consensus.
It is instructive to consider why there It is instructive to consider why there has been so much debate about the diaghas been so much debate about the diagnosis of diabetes. Plasma glucose concentranosis of diabetes. Plasma glucose concentrations show a skewed normal distribution in tions show a skewed normal distribution in the general population, and the delineation the general population, and the delineation of abnormal from normal thus becomes of abnormal from normal thus becomes arbitrary. The WHO and ADA diagnostic arbitrary. The WHO and ADA diagnostic criteria reflect the concentration of plasma criteria reflect the concentration of plasma glucose at which there is an association with glucose at which there is an association with the development of microvascular comthe development of microvascular complications, particularly retinopathy (Pettitt plications, particularly retinopathy (Pettitt et al et al, 1980) . Although the relationship , 1980). Although the relationship between the exposure to hyperglycaemia between the exposure to hyperglycaemia and microvascular complications is expoand microvascular complications is exponential -allowing for a diagnostic cut-off nential -allowing for a diagnostic cut-off at the inflection of the curve -the relationat the inflection of the curve -the relationship between hyperglycaemia and macroship between hyperglycaemia and macrovascular complications is more linear, vascular complications is more linear, suggesting that there is no threshold for suggesting that there is no threshold for the development of cardiovascular disease the development of cardiovascular disease ( Fig. 1 ; Stratton ( Fig. 1 ; Stratton et al et al, 2000) . This implies , 2000) . This implies that cardiovascular risk will also increase that cardiovascular risk will also increase with increases in blood glucose concenwith increases in blood glucose concentrations across the normal population. trations across the normal population.
The WHO diagnostic criteria also The WHO diagnostic criteria also recognise two further categories: impaired recognise two further categories: impaired fasting glycaemia and impaired glucose fasting glycaemia and impaired glucose tolerance; the latter can only be diagnosed tolerance; the latter can only be diagnosed following a 75 g oral glucose tolerance test. following a 75 g oral glucose tolerance test. Impaired fasting glycaemia and impaired Impaired fasting glycaemia and impaired glucose tolerance are not distinct clinical glucose tolerance are not distinct clinical entities, but rather risk factors for future entities, but rather risk factors for future diabetes and cardiovascular disease diabetes and cardiovascular disease (DECODE Study Group, 2001 ). Indeed, (DECODE Study Group, 2001 ). Indeed, the ADA has suggested that the new term the ADA has suggested that the new term 'pre-diabetes' be used to describe both 'pre-diabetes' be used to describe both these abnormalities (American Diabetes these abnormalities (American Diabetes Association, 2002) . Association, 2002) .
A diagnosis of diabetes has important A diagnosis of diabetes has important social, legal and medical implications for social, legal and medical implications for the patient, and it is therefore essential that the patient, and it is therefore essential that any diagnosis is secure. Diabetes should any diagnosis is secure. Diabetes should not be diagnosed on the basis of glyconot be diagnosed on the basis of glycosuria, and the blood glucose concentration suria, and the blood glucose concentration should be measured on a venous plasma should be measured on a venous plasma sample in an accredited laboratory (World sample in an accredited laboratory (World Health Organization, 1999) . At present, Health Organization, 1999 . Although type 1 diabetes affects all age groups, the majority of individuals age groups, the majority of individuals are diagnosed either at around the age of are diagnosed either at around the age of 4-5 years, or in their teens and early 4-5 years, or in their teens and early adulthood (Bloom adulthood (Bloom et al et al, 1975) . , 1975). The incidence of type 1 diabetes is The incidence of type 1 diabetes is rising. Across Europe, the average annual rising. Across Europe, the average annual increase in the incidence in children under increase in the incidence in children under 15 years old is 3.4% (EURODIAB ACE 15 years old is 3.4% (EURODIAB ACE Study Group, 2000) , with the steepest rise Study Group, 2000) , with the steepest rise in those under 5 years old (Karvonen in those under 5 years old (Karvonen et et al al, 1999) . , 1999).
Aetiology Aetiology
The aetiology of type 1 diabetes remains The aetiology of type 1 diabetes remains poorly understood, but it is likely that an poorly understood, but it is likely that an environmental factor triggers an autoenvironmental factor triggers an autoimmune process in a predisposed individimmune process in a predisposed individual. (Table 2) . A marked geographical 2025 (Table 2) . A marked geographical variation in the prevalence of type 2 variation in the prevalence of type 2 diabetes exists (Zimmet, 1982) . The highest diabetes exists (Zimmet, 1982) . The highest rates are found in the Pima Native rates are found in the Pima Native Americans of Arizona and in the inhabitants Americans of Arizona and in the inhabitants of the South Pacific island of Nauru, where of the South Pacific island of Nauru, where approximately half the adult population approximately half the adult population have diabetes. In contrast, in the rural comhave diabetes. In contrast, in the rural communities of China and Chile, the prevalence munities of China and Chile, the prevalence is less than 1%. In general, rates of type 2 is less than 1%. In general, rates of type 2 diabetes are higher in urban populations diabetes are higher in urban populations than in rural communities (Zimmet, 1982) . than in rural communities (Zimmet, 1982) .
Regional and ethnic differences in the Regional and ethnic differences in the prevalence of type 2 diabetes reflect not prevalence of type 2 diabetes reflect not only differences in environment, but also only differences in environment, but also differences in genetic susceptibility. For exdifferences in genetic susceptibility. For example, in the UK people from the Indian ample, in the UK people from the Indian subcontinent living in Southall have a rate subcontinent living in Southall have a rate of diabetes four times higher than the local of diabetes four times higher than the local White population (Mather & Keen, 1985) . White population (Mather & Keen, 1985) .
Genetic predisposition Genetic predisposition. The heritability of . The heritability of type 2 diabetes is greater than for type 1 type 2 diabetes is greater than for type 1 diabetes, and is estimated to account for diabetes, and is estimated to account for 40-80% of total disease susceptibility. 40-80% of total disease susceptibility. Many patients will have a family history Many patients will have a family history of diabetes (Thomas of diabetes (Thomas et al et al, 1994), and , 1994) , and twin studies show a high concordance rate twin studies show a high concordance rate (60-90%) in monozygotic twins (Barnett (60-90%) in monozygotic twins (Barnett et al et al, 1981) . A maternal history of diabetes , 1981). A maternal history of diabetes confers a higher risk of type 2 diabetes in confers a higher risk of type 2 diabetes in the offspring than a paternal history of the offspring than a paternal history of diabetes (Thomas diabetes (Thomas et al et al, 1994) , possibly , 1994), possibly through an effect of maternal hyperglycaethrough an effect of maternal hyperglycaemia during pregnancy (Pettitt mia during pregnancy (Pettitt et al et al, 1993) . , 1993). Type 2 diabetes is a polygenic disorder, Type 2 diabetes is a polygenic disorder, and it is clear that no single major locus and it is clear that no single major locus explains its inheritance. There appear to explains its inheritance. There appear to be many candidate genes involved in conbe many candidate genes involved in controlling insulin secretion and action, and trolling insulin secretion and action, and these are all likely to play a part in the these are all likely to play a part in the development of type 2 diabetes. development of type 2 diabetes.
Environmental factors Environmental factors. The most important
. The most important environmental risk factors for diabetes are environmental risk factors for diabetes are obesity and physical inactivity. The massive obesity and physical inactivity. The massive explosion in obesity rates worldwide has explosion in obesity rates worldwide has largely been responsible for the increase in largely been responsible for the increase in diabetes, and it is estimated that up to diabetes, and it is estimated that up to 80% of all new cases of diabetes can be at-80% of all new cases of diabetes can be attributed to obesity (Lean, 2000) . In the UK, tributed to obesity (Lean, 2000) . In the UK, the average body mass index ( In addition to total adiposity, the distriIn addition to total adiposity, the distribution of fat is important. For any given bution of fat is important. For any given s 5 7 s 5 7 level of obesity, the more visceral fat an level of obesity, the more visceral fat an individual has, the greater the risk of individual has, the greater the risk of developing diabetes (Carey developing diabetes (Carey et al et al, 1997) . , 1997). Physical inactivity is also associated with Physical inactivity is also associated with an increased risk of diabetes (Hu an increased risk of diabetes (Hu et al et al, , 1999 ). In the US Nurses' Health Study, 1999). In the US Nurses' Health Study, those in the top quintile for exercise those in the top quintile for exercise (equivalent to more than 200 min of (equivalent to more than 200 min of exercise per week) had a 46% lower risk exercise per week) had a 46% lower risk of diabetes compared with those in the of diabetes compared with those in the lowest quintile (less than 20 min of exerlowest quintile (less than 20 min of exercise). Although some of the difference can cise). Although some of the difference can be explained by differences in adiposity, be explained by differences in adiposity, after adjusting for BMI those in the most after adjusting for BMI those in the most active quintile still had a 26% reduction active quintile still had a 26% reduction in risk of diabetes. in risk of diabetes.
The intrauterine environment is also The intrauterine environment is also considered to be important in the developconsidered to be important in the development of type 2 diabetes. There are now over ment of type 2 diabetes. There are now over 48 reports linking poor foetal growth with 48 reports linking poor foetal growth with impaired glucose metabolism in later life impaired glucose metabolism in later life (Newsome (Newsome et al et al, 2003) . In most of these , 2003). In most of these studies, birth weight has an inverse studies, birth weight has an inverse relationship with plasma glucose and insurelationship with plasma glucose and insulin concentrations, the prevalence of type 2 lin concentrations, the prevalence of type 2 diabetes and measures of insulin resistance diabetes and measures of insulin resistance and secretion. Birth weight is a crude meaand secretion. Birth weight is a crude measure of foetal growth, and it appears that sure of foetal growth, and it appears that adult glucose intolerance is more closely adult glucose intolerance is more closely associated with thinness at birth, as associated with thinness at birth, as assessed by the birth ponderal index assessed by the birth ponderal index (weight/length (weight/length 3 3 ) (Phillips ) (Phillips et al et al, 1994) . , 1994).
Pathogenesis Pathogenesis
Under normal physiological conditions, Under normal physiological conditions, plasma glucose concentrations are mainplasma glucose concentrations are maintained within a narrow range, despite wide tained within a narrow range, despite wide fluctuations in supply and demand, through fluctuations in supply and demand, through a tightly regulated and dynamic interaction a tightly regulated and dynamic interaction between tissue sensitivity to insulin (espebetween tissue sensitivity to insulin (especially in the liver) and insulin secretion cially in the liver) and insulin secretion (DeFronzo, 1988) . In type 2 diabetes these (DeFronzo, 1988) . In type 2 diabetes these mechanisms break down, with the consemechanisms break down, with the consequence that the two main pathophysioquence that the two main pathophysiological defects in type 2 diabetes are logical defects in type 2 diabetes are impaired insulin secretion through a impaired insulin secretion through a dysfunction of the pancreatic dysfunction of the pancreatic b b-cell, and -cell, and impaired insulin action through insulin impaired insulin action through insulin resistance. resistance.
Insulin resistance Insulin resistance. Insulin resistance is now . Insulin resistance is now regarded as being synonymous with a reregarded as being synonymous with a reduced rate of whole-body insulin-mediated duced rate of whole-body insulin-mediated glucose disposal in insulin-sensitive tissues glucose disposal in insulin-sensitive tissues (DeFronzo & Ferrannini, 1991; Moller & (DeFronzo & Ferrannini, 1991; Moller & Flier, 1991) . This definition is too narrow, Flier, 1991) . This definition is too narrow, and insulin resistance may be better defined and insulin resistance may be better defined as existing when normal insulin concentraas existing when normal insulin concentrations fail to produce a normal biological tions fail to produce a normal biological response (Kahn, 1978) . The main advanresponse (Kahn, 1978) . The main advantage of the latter definition is that it does tage of the latter definition is that it does not restrict consideration of insulin action not restrict consideration of insulin action to a solitary aspect of intermediary metaboto a solitary aspect of intermediary metabolism. lism.
The importance of insulin actions on The importance of insulin actions on other aspects of intermediary metabolism, other aspects of intermediary metabolism, including lipid and protein metabolism, including lipid and protein metabolism, has now been appreciated. In 1988, Reahas now been appreciated. In 1988, Reaven described syndrome X (now commonly ven described syndrome X (now commonly known as the metabolic syndrome or insuknown as the metabolic syndrome or insulin resistance syndrome) as the association lin resistance syndrome) as the association between several cardiovascular risk factors, between several cardiovascular risk factors, including hypertension, dyslipidaemia and including hypertension, dyslipidaemia and glucose tolerance, and he proposed that glucose tolerance, and he proposed that insulin resistance was the underlying cause insulin resistance was the underlying cause (Reaven, 1988) . Since his original descrip- (Reaven, 1988) . Since his original description, it has been recognised that a signifition, it has been recognised that a significant proportion of patients with the cant proportion of patients with the metabolic syndrome do not have insulin remetabolic syndrome do not have insulin resistance (Ford sistance (Ford et al et al, 2002) . The definition , 2002) . The definition of the metabolic syndrome has therefore of the metabolic syndrome has therefore been modified: most notably, central obebeen modified: most notably, central obesity has been added as a core feature. This sity has been added as a core feature. This is important, as it is increasingly recogis important, as it is increasingly recognised that central obesity is fundamental nised that central obesity is fundamental to the origin of this disorder (Maison to the origin of this disorder (Maison et et al al, 2001) .
,
2001). The metabolic syndrome is thought to
The metabolic syndrome is thought to affect just under a quarter of American affect just under a quarter of American adults (Ford adults (Ford et al et al, 2002) , and it is known , 2002), and it is known to be a significant risk factor for type 2 diato be a significant risk factor for type 2 diabetes and cardiovascular disease. However, betes and cardiovascular disease. However, one major problem with the concept of the one major problem with the concept of the metabolic syndrome has been the lack of metabolic syndrome has been the lack of specific diagnostic criteria or an easy measpecific diagnostic criteria or an easy measure of insulin resistance. Fortunately, the sure of insulin resistance. Fortunately, the publication of diagnostic criteria, by the publication of diagnostic criteria, by the National Cholesterol Education Program National Cholesterol Education Program and the WHO (Table 3) , has largely rectiand the WHO (Table 3) Beta-cell dysfunction Beta-cell dysfunction. In response to glu-. In response to glucose, insulin is secreted in a characteristic cose, insulin is secreted in a characteristic biphasic pattern: an acute first phase lasting biphasic pattern: an acute first phase lasting a few minutes, followed by a sustained seca few minutes, followed by a sustained second phase. The major ond phase. The major b b-cell abnormalities -cell abnormalities in type 2 diabetes are a marked reduction in type 2 diabetes are a marked reduction in first-phase insulin secretion and, in estabin first-phase insulin secretion and, in established diabetes, an attenuated second phase. lished diabetes, an attenuated second phase.
Abnormalities in Abnormalities in b b-cell function are -cell function are found early in the natural history of type 2 found early in the natural history of type 2 diabetes and in first-degree relatives of diabetes and in first-degree relatives of s 5 8 s 5 8 Group, 1995) . By the time Diabetes Study Group, 1995) . By the time of diagnosis, mean of diagnosis, mean b b-cell function was -cell function was already less than 50%, and further already less than 50%, and further deterioration of deterioration of b b-cell function was not -cell function was not prevented by any of the diabetic therapies prevented by any of the diabetic therapies used in the study. used in the study.
Extrapolation of the observed rate of Extrapolation of the observed rate of b b--cell decline suggests that the loss of cell decline suggests that the loss of b b-cell -cell function begins around 12 years prior to function begins around 12 years prior to diagnosis (Holman, 1998; Fig. 3 ). This diagnosis (Holman, 1998; Fig. 3 ). This progressive loss of progressive loss of b b-cell function explains -cell function explains why patients require escalations in the why patients require escalations in the number and dosage of oral hypoglycaemic number and dosage of oral hypoglycaemic agents with time, and why eventually they agents with time, and why eventually they become refractory to the oral treatments become refractory to the oral treatments and require insulin. and require insulin.
Although the mechanisms underlying Although the mechanisms underlying the the b b-cell dysfunction remain unclear, they -cell dysfunction remain unclear, they are likely to be multifactorial. As well as are likely to be multifactorial. As well as genetic factors (Pratley & Weyer, 2001 ), a genetic factors (Pratley & Weyer, 2001 ), a number of environmental factors (including number of environmental factors (including early-life malnutrition and obesity) and early-life malnutrition and obesity) and hyperglycaemia and hyperlipidaemia hyperglycaemia and hyperlipidaemia per se per se may all accelerate the decline in may all accelerate the decline in b b-cell func--cell function (Hales tion (Hales et al et al, 1991; Prentki , 1991; Prentki et al et al, 2002) . , 2002). There has been much discussion about There has been much discussion about the relative roles of insulin resistance and the relative roles of insulin resistance and b b-cell function in the natural history of dia--cell function in the natural history of diabetes, since both components occur early in betes, since both components occur early in the disease process. One model for the the disease process. One model for the development of diabetes is shown in Fig. 4 . development of diabetes is shown in Fig. 4 .
As insulin sensitivity falls, the As insulin sensitivity falls, the b b-cell -cell responds by increasing insulin secretion to responds by increasing insulin secretion to compensate and to maintain glucose concompensate and to maintain glucose concentrations within the normal range. The centrations within the normal range. The maximal insulin secretory capacity is maximal insulin secretory capacity is eventually reached and, beyond that point, eventually reached and, beyond that point, insulin secretion declines. The blood insulin secretion declines. The blood glucose concentrations rise, initially in the glucose concentrations rise, initially in the postprandial period, as the individual postprandial period, as the individual develops impaired glucose tolerance before develops impaired glucose tolerance before the onset of frank diabetes. the onset of frank diabetes.
This process may, however, be reversiThis process may, however, be reversible. Although around 2-5% of individuals ble. Although around 2-5% of individuals with impaired glucose tolerance will with impaired glucose tolerance will progress to diabetes each year, many revert progress to diabetes each year, many revert to normal (Saad to normal (Saad et al et al, 1988) , and since , 1988), and since there is good evidence to show that lifestyle there is good evidence to show that lifestyle intervention at this stage can reduce intervention at this stage can reduce incident diabetes, people falling into these incident diabetes, people falling into these categories should be managed actively with categories should be managed actively with advice about their diet and exercise (Pan advice about their diet and exercise (Pan et et al al, 1997; Tuomilehto , 1997; Tuomilehto et al et al, 2001; Knowler , 2001; Knowler et al et al, 2002) .
, 2002).
Drug-induced diabetes Drug-induced diabetes
Many drugs can worsen or precipitate Many drugs can worsen or precipitate hyperglycaemia through a number of hyperglycaemia through a number of mechanisms. These include drugs that are mechanisms. These include drugs that are directly toxic to the directly toxic to the b b-cell, such as cyclo--cell, such as cyclosporin and pentamidine, or drugs that sporin and pentamidine, or drugs that worsen insulin resistance, such as glucocorworsen insulin resistance, such as glucocorticoids and high-dose thiazide diuretics. ticoids and high-dose thiazide diuretics. These effects are often reversible, but other These effects are often reversible, but other treatments should be used whenever posstreatments should be used whenever possible. Where no alternative exists, careful ible. Where no alternative exists, careful monitoring of glycaemic control and treatmonitoring of glycaemic control and treatment of the diabetes can mitigate the effect ment of the diabetes can mitigate the effect of these drugs. of these drugs.
Hyperglycaemia has been reported with Hyperglycaemia has been reported with both conventional and atypical antiboth conventional and atypical antipsychotic drugs. These drugs are not psychotic drugs. These drugs are not directly toxic to the directly toxic to the , 2001 ), so the underlying mechanism has been asthe underlying mechanism has been assumed to be through an increase in insulin sumed to be through an increase in insulin resistance (Sowell resistance (Sowell et al et al, 2002) . However, , 2002). However, s 5 9 s 5 9 since there is no direct relationship between since there is no direct relationship between weight gain and the development of diaweight gain and the development of diabetes, other mechanisms are thought to be betes, other mechanisms are thought to be involved (Jin involved (Jin et al et al, 2002) . This is discussed , 2002). This is discussed in greater detail by Haddad (2004, 
Clinical features of type 2 diabetes Clinical features of type 2 diabetes
Type 2 diabetes usually affects overweight Type 2 diabetes usually affects overweight individuals, and most cases are diagnosed individuals, and most cases are diagnosed in those over 40 years old (Jonsson, 2002) . in those over 40 years old (Jonsson, 2002) . However, the demographics of this disease However, the demographics of this disease are changing, and it is now becoming are changing, and it is now becoming increasingly common in children and young increasingly common in children and young adults (American Diabetes Association, adults (American Diabetes Association, 2000). 2000).
Type 2 diabetes has a gradual and Type 2 diabetes has a gradual and insidious onset, with nearly a third of cases insidious onset, with nearly a third of cases being identified as an incidental finding being identified as an incidental finding (1988) or in the coronary care unit (1988) or in the coronary care unit (Malmberg (Malmberg et al et al, 1995) . The diagnosis is , 1995). The diagnosis is often delayed, and some degree of hyperoften delayed, and some degree of hyperglycaemia may have been present for more glycaemia may have been present for more than 20 years before the diagnosis is than 20 years before the diagnosis is confirmed (Liu confirmed (Liu et al et al, 2002) . This accounts , 2002). This accounts for the so-called 'missing million' people for the so-called 'missing million' people with undiagnosed diabetes in the UK. The with undiagnosed diabetes in the UK. The Isle of Ely Diabetes Project was undertaken Isle of Ely Diabetes Project was undertaken to determine the prevalence of undiagnosed to determine the prevalence of undiagnosed glucose intolerance in this community glucose intolerance in this community (Williams (Williams et al et al, 1995) . Of the 1122 , 1995). Of the 1122 participants in the study, 4.5% were found participants in the study, 4.5% were found to have undiagnosed diabetes, and 16.8% to have undiagnosed diabetes, and 16.8% were found to have impaired glucose were found to have impaired glucose tolerance. This high prevalence of undiagtolerance. This high prevalence of undiagnosed diabetes in the general population nosed diabetes in the general population should be borne in mind when interpreting should be borne in mind when interpreting epidemiological data assessing the effects of epidemiological data assessing the effects of antipsychotic medications on the developantipsychotic medications on the development of diabetes. ment of diabetes.
Around half of patients with type 2 diaAround half of patients with type 2 diabetes are diagnosed as a result of the typical betes are diagnosed as a result of the typical diabetic symptoms of polyuria, nocturia, diabetic symptoms of polyuria, nocturia, thirst, tiredness and blurred vision; a further thirst, tiredness and blurred vision; a further 16% of patients are diagnosed after pre-16% of patients are diagnosed after presenting with an infection (UK Prospective senting with an infection (UK Prospective Diabetes Study Group, 1988) . MicrovascuDiabetes Study Group, 1988) . Microvascular diabetic complications are frequently lar diabetic complications are frequently present at the time of diagnosis, but account present at the time of diagnosis, but account for only 2% of all presentations. for only 2% of all presentations.
Prevention of diabetes Prevention of diabetes
One of the most exciting areas in diabetes One of the most exciting areas in diabetes at present is a focus on the possibility that at present is a focus on the possibility that type 2 diabetes can be prevented, or at least type 2 diabetes can be prevented, or at least its onset delayed. Interest in this area has its onset delayed. Interest in this area has been rekindled by the publication of studies been rekindled by the publication of studies showing that both lifestyle and pharmacoshowing that both lifestyle and pharmacological interventions can reduce incident logical interventions can reduce incident diabetes. diabetes.
Lifestyle studies Lifestyle studies
The first randomised study to show that The first randomised study to show that lifestyle interventions could reduce diabetes lifestyle interventions could reduce diabetes was the Da Qing Impaired Glucose Tolerwas the Da Qing Impaired Glucose Tolerance and Diabetes Study published in ance and Diabetes Study published in 1997 (Pan 1997 (Pan et al et al, 1997 . Individuals with , 1997). Individuals with impaired glucose tolerance who were impaired glucose tolerance who were randomised to receive a dietary interrandomised to receive a dietary intervention, an exercise intervention, or a comvention, an exercise intervention, or a combination of both, had a nearly 50% bination of both, had a nearly 50% reduction in risk of diabetes over 6 years reduction in risk of diabetes over 6 years compared with a control group. compared with a control group. In the Finnish study, 523 overpublished. In the Finnish study, 523 overweight individuals aged 40-65 years with weight individuals aged 40-65 years with impaired glucose tolerance were randomly impaired glucose tolerance were randomly assigned to a control or lifestyle interassigned to a control or lifestyle intervention group and were followed for a vention group and were followed for a mean of 3.2 years. The control group was mean of 3.2 years. The control group was given general verbal and written inforgiven general verbal and written information about a healthy diet and exercise; mation about a healthy diet and exercise; the intervention group received individualthe intervention group received individualised dietary counselling, aimed at reducing ised dietary counselling, aimed at reducing weight by 5%, reducing total fat and weight by 5%, reducing total fat and saturated fat intake (to less than 30% and saturated fat intake (to less than 30% and 10% of total energy intake, respectively) 10% of total energy intake, respectively) and increasing intake of fibre, given in and increasing intake of fibre, given in frequent face-to-face sessions with a dietfrequent face-to-face sessions with a dietician. The intervention group members ician. The intervention group members were encouraged to undertake 30 min of were encouraged to undertake 30 min of aerobic exercise and resistance training aerobic exercise and resistance training per day through individually designed per day through individually designed programmes. The proportion of individuals programmes. The proportion of individuals who progressed to diabetes was reduced who progressed to diabetes was reduced from 7.8% per annum in the control group from 7.8% per annum in the control group to 3.2% per annum in the intervention to 3.2% per annum in the intervention group -a substantial risk reduction of group -a substantial risk reduction of 58%. The rate of diabetes was found to 58%. The rate of diabetes was found to be related to the number of targets be related to the number of targets achieved; there were no cases of diabetes achieved; there were no cases of diabetes during the study in those who achieved four during the study in those who achieved four or five of the targets. or five of the targets.
The Diabetes Prevention Program comThe Diabetes Prevention Program compared the effectiveness of intensive lifestyle pared the effectiveness of intensive lifestyle modifications similar to those used in the modifications similar to those used in the Finnish study with metformin (850 mg Finnish study with metformin (850 mg twice daily) treatment in preventing type 2 twice daily) treatment in preventing type 2 diabetes (Knowler diabetes (Knowler et al et al, 2002) . Originally, , 2002 ). Originally, a third group received the thiazolidinedione a third group received the thiazolidinedione troglitazone, but this arm of the study was troglitazone, but this arm of the study was stopped after the drug was withdrawn from stopped after the drug was withdrawn from the market. A major strength of the the market. A major strength of the Diabetes Prevention Program was its size Diabetes Prevention Program was its size and diversity: 3234 people with impaired and diversity: 3234 people with impaired glucose tolerance took part, of whom 45% glucose tolerance took part, of whom 45% had non-White European backgrounds and had non-White European backgrounds and 68% were women. After an average 68% were women. After an average follow-up period of 2.8 years, the incidence follow-up period of 2.8 years, the incidence of diabetes in the lifestyle intervention of diabetes in the lifestyle intervention group was reduced by 58%; metformin regroup was reduced by 58%; metformin reduced incident diabetes by 31%. Since none duced incident diabetes by 31%. Since none of the trial participants received both the of the trial participants received both the lifestyle intervention and metformin, it is lifestyle intervention and metformin, it is interesting to speculate whether further interesting to speculate whether further s 6 0 s 6 0 Natural history of insulin resistance and insulin secretion in type 2 diabetes.
benefits might accrue from combining these benefits might accrue from combining these interventions. A remarkable observation in interventions. A remarkable observation in both the Finnish and the American studies both the Finnish and the American studies was that the impressive reductions in diawas that the impressive reductions in diabetes were achieved with only moderate betes were achieved with only moderate reductions in weight. reductions in weight. Unfortunately, it is unlikely that the Unfortunately, it is unlikely that the lifestyle intervention used in these studies lifestyle intervention used in these studies could ever be replicated outside a research could ever be replicated outside a research setting. Public health policies are therefore setting. Public health policies are therefore urgently required that will encourage urgently required that will encourage people to adopt a healthy lifestyle and people to adopt a healthy lifestyle and prevent the development of impaired prevent the development of impaired glucose tolerance and diabetes. Primary glucose tolerance and diabetes. Primary prevention strategies should target individprevention strategies should target individuals at especially high risk of developing uals at especially high risk of developing type 2 diabetes, including those with pretype 2 diabetes, including those with prediabetes, first-degree relatives of people diabetes, first-degree relatives of people with type 2 diabetes, women with a history with type 2 diabetes, women with a history of gestational diabetes, individuals with of gestational diabetes, individuals with other features of the metabolic syndrome other features of the metabolic syndrome (Zimmet (Zimmet et al et al, 2003 (Zimmet et al et al, ) and, I suggest, those , 2003 and, I suggest, those with severe mental illness. with severe mental illness.
Pharmacological intervention Pharmacological intervention
In addition to the Diabetes Prevention In addition to the Diabetes Prevention Program, there have been several other Program, there have been several other pharmacological intervention studies. The pharmacological intervention studies. The STOP-NIDDM trial was designed to evalu-STOP-NIDDM trial was designed to evaluate the effect of acarbose, an ate the effect of acarbose, an a a-glucosidase -glucosidase inhibitor, in reducing the risk of type 2 inhibitor, in reducing the risk of type 2 diabetes (Chiasson diabetes (Chiasson et al et al, 2002) . After a , 2002). After a mean follow-up of 3.3 years, a 25% mean follow-up of 3.3 years, a 25% relative risk reduction in progression to relative risk reduction in progression to diabetes was observed in the acarbosediabetes was observed in the acarbosetreated group compared with the placebo treated group compared with the placebo group, with an absolute risk reduction in group, with an absolute risk reduction in the acarbose-treated group of 9%. the acarbose-treated group of 9%.
In the TRIPOD study (Buchanan In the TRIPOD study (Buchanan et al et al, , 2002) , 236 Hispanic women with previous 2002), 236 Hispanic women with previous gestational diabetes were randomized to gestational diabetes were randomized to receive either placebo or troglitazone. After receive either placebo or troglitazone. After a median follow-up of 30 months, troglitaa median follow-up of 30 months, troglitazone treatment was associated with a 56% zone treatment was associated with a 56% relative reduction in incident diabetes. relative reduction in incident diabetes. Furthermore, a beneficial effect of the drug Furthermore, a beneficial effect of the drug was seen during the 8-month wash-out was seen during the 8-month wash-out period immediately after the end of the period immediately after the end of the trial, suggesting that troglitazone might trial, suggesting that troglitazone might affect the natural history of glucose intoleraffect the natural history of glucose intolerance, thereby preventing diabetes in some ance, thereby preventing diabetes in some people. people.
The results of the XENDOS study The results of the XENDOS study have recently been published (Torgerson have recently been published (Torgerson et al et al, 2004) . In this study, the use of , 2004). In this study, the use of orlistat plus lifestyle interventions reduced orlistat plus lifestyle interventions reduced the risk of developing type 2 diabetes by the risk of developing type 2 diabetes by 37% compared with lifestyle interventions 37% compared with lifestyle interventions alone. Furthermore, improvements in alone. Furthermore, improvements in other cardiovascular risk factors, including other cardiovascular risk factors, including blood pressure and lipid profile, were also blood pressure and lipid profile, were also achieved. achieved.
Screening for diabetes Screening for diabetes
The high prevalence of undiagnosed diaThe high prevalence of undiagnosed diabetes and the proportion of patients with betes and the proportion of patients with evidence of complications at diagnosis evidence of complications at diagnosis undoubtedly create a strong imperative for undoubtedly create a strong imperative for screening. Many possible screening methscreening. Many possible screening methods have been shown to be feasible, accepods have been shown to be feasible, acceptable and accurate (Wareham & Griffin, table and accurate (Wareham & Griffin, 2001 ), but there is still debate about whom 2001), but there is still debate about whom to screen. Universal screening for diabetes to screen. Universal screening for diabetes is currently impractical because of the buris currently impractical because of the burden that would be placed upon general den that would be placed upon general practitioners (Wylie practitioners (Wylie et al et al, 2002) . There is , 2002). There is justification, however, for screening highjustification, however, for screening highrisk groups in whom undiagnosed diabetes risk groups in whom undiagnosed diabetes is especially prevalent. Patients with schizois especially prevalent. Patients with schizophrenia fall within this high-risk category, phrenia fall within this high-risk category, and therefore should be considered for and therefore should be considered for screening for diabetes. This is discussed in screening for diabetes. This is discussed in greater detail by Gough & Peveler (2004 , greater detail by Gough & Peveler (2004 . this supplement).
Complications of type 2 diabetes Complications of type 2 diabetes
Since the introduction of effective treatSince the introduction of effective treatment that allows patients with diabetes ment that allows patients with diabetes to live through the acute metabolic conseto live through the acute metabolic consequences of the illness, it has become apquences of the illness, it has become apparent that diabetes is associated with a parent that diabetes is associated with a number of chronic microvascular complinumber of chronic microvascular complications, which affect the eyes, kidneys cations, which affect the eyes, kidneys and nervous system, and macrovascular and nervous system, and macrovascular complications, which lead to an increased complications, which lead to an increased risk of myocardial infarction, stroke and risk of myocardial infarction, stroke and peripheral vascular disease. peripheral vascular disease.
Microvascular complications Microvascular complications
Microvascular complications are frequently Microvascular complications are frequently present at diagnosis in patients with type 2 present at diagnosis in patients with type 2 diabetes. Retinopathy and cataracts each diabetes. Retinopathy and cataracts each affect around 15% of individuals with affect around 15% of individuals with type 2 diabetes and are frequently present type 2 diabetes and are frequently present at diagnosis (UK Prospective Diabetes at diagnosis (UK Prospective Diabetes Study Group, 1988; American Diabetes Study Group, 1988; American Diabetes Association, 2001 ). Maculopathy -a retiAssociation, 2001). Maculopathy -a retinopathy affecting the macula and therefore nopathy affecting the macula and therefore the central vision -is the most common the central vision -is the most common cause of sight-threatening retinopathy in cause of sight-threatening retinopathy in type 2 diabetes; proliferative retinopathytype 2 diabetes; proliferative retinopathythe most common cause of sight-threatening the most common cause of sight-threatening retinopathy in type 1 diabetes -is less retinopathy in type 1 diabetes -is less common. common.
The risk of developing nephropathy is The risk of developing nephropathy is lower in type 2 diabetes than in type 1 dialower in type 2 diabetes than in type 1 diabetes because of the generally later onset of betes because of the generally later onset of the former disorder. The prevalence of the former disorder. The prevalence of microalbuminuria -a higher than normal microalbuminuria -a higher than normal albumin excretion that cannot be detected albumin excretion that cannot be detected by standard urine reagent strips and a sign by standard urine reagent strips and a sign of early diabetic nephropathy -is around of early diabetic nephropathy -is around 25-30%. Approximately 5-13% of pa-25-30%. Approximately 5-13% of patients with type 2 diabetes have frank tients with type 2 diabetes have frank proteinuria (American Diabetes Associaproteinuria (American Diabetes Association, 2001 ). Although the individual risk tion, 2001). Although the individual risk of developing end-stage renal failure is of developing end-stage renal failure is lower in type 2 diabetes, patients with this lower in type 2 diabetes, patients with this form of diabetes requiring renal replaceform of diabetes requiring renal replacement therapy outnumber patients with ment therapy outnumber patients with type 1 diabetes because of the much greater type 1 diabetes because of the much greater prevalence of type 2 diabetes. prevalence of type 2 diabetes.
Neuropathy affects 20-50% of patients Neuropathy affects 20-50% of patients with type 2 diabetes, and its sequelae, such with type 2 diabetes, and its sequelae, such as foot ulceration and amputation, cause as foot ulceration and amputation, cause considerable morbidity and mortality (Boulconsiderable morbidity and mortality (Boulton & Malik, 1998) . Fifteen per cent of peoton & Malik, 1998). Fifteen per cent of people with type 2 diabetes develop foot ulcers, ple with type 2 diabetes develop foot ulcers, of whom 5-15% require foot amputations. of whom 5-15% require foot amputations.
Macrovascular disease Macrovascular disease
Diabetes confers a two-fold to four-fold inDiabetes confers a two-fold to four-fold increased risk of myocardial infarction and creased risk of myocardial infarction and stroke in men, and up to a ten-fold instroke in men, and up to a ten-fold increased risk in pre-menopausal women creased risk in pre-menopausal women (2001). Mortality following a myocardial (2001). Mortality following a myocardial infarction is far greater in people with diainfarction is far greater in people with diabetes. Furthermore, 60-75% of all people betes. Furthermore, 60-75% of all people with diabetes die from cardiovascular diswith diabetes die from cardiovascular disease (Stamler ease (Stamler et al et al, 1993) . These statistics, , 1993). These statistics, coupled with the observation that people coupled with the observation that people with diabetes who have not had a previous with diabetes who have not had a previous myocardial infarction share the same risk myocardial infarction share the same risk of having a myocardial infarction as nonof having a myocardial infarction as nondiabetic patients who have had a myodiabetic patients who have had a myocardial infarction (Haffner cardial infarction (Haffner et al et al, 1998 (Haffner et al et al, ), , 1998 , have begun to shift the focus of managehave begun to shift the focus of management of diabetes from glucose control to a ment of diabetes from glucose control to a greater emphasis on arterial risk-factor greater emphasis on arterial risk-factor management. management.
Hyperglycaemia Hyperglycaemia per se per se is insufficient to is insufficient to explain the increased prevalence of cardioexplain the increased prevalence of cardiovascular disease in diabetes, and it is my vascular disease in diabetes, and it is my belief that increased prevalence of metabelief that increased prevalence of metabolic syndrome features in people with bolic syndrome features in people with diabetes largely explains the excess cardiodiabetes largely explains the excess cardiovascular disease in these patients (Stratton vascular disease in these patients (Stratton et al et al, 2000) . In the Prospective Cardio-, 2000) . In the Prospective Cardiovascular Munster Study, for example, vascular Mü nster Study, for example, 49% of individuals with diabetes had hyper-49% of individuals with diabetes had hypertension, 24% had a low level of high-density tension, 24% had a low level of high-density lipoprotein cholesterol and 37% had hyperlipoprotein cholesterol and 37% had hypertrigylceridaemia, compared with values of trigylceridaemia, compared with values of 31%, 16% and 21%, respectively, in people 31%, 16% and 21%, respectively, in people without diabetes (Assmann & Schulte, without diabetes (Assmann & Schulte, 1988 
DISCUSSION DISCUSSION
Diabetes is already a costly disease in Diabetes is already a costly disease in individual, social and economic terms, and individual, social and economic terms, and the global burden of diabetes is increasing. the global burden of diabetes is increasing. Diabetes is associated with premature morDiabetes is associated with premature morbidity and mortality, and it should never be bidity and mortality, and it should never be considered to be a 'mild' condition. Many considered to be a 'mild' condition. Many people with diabetes have asymptomatic people with diabetes have asymptomatic disease, and it is hoped that, with improved disease, and it is hoped that, with improved screening procedures and better treatments, screening procedures and better treatments, the long-term outlook for these individuals the long-term outlook for these individuals will be greatly improved. will be greatly improved. 
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